|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pulmonary artery aneurysms in Beheet's syndrome: a report of 24 cases 显示文摘 | Hamuryudan V Yurdakul S Moral F | 1994 | Br J Rheumatol1994，33，： | 1 |
| 2 | Inefficacy of azapropazone in the acute arthritis of Behcet's syndrome:a randomized,double blind,placebo controlled study显示文摘 | Moral F Hamuryudan V Yurdakul S | 1995 | Clinical & Experimental Rheumatology1995，13，： | 1 |
| 3 | Pulmonary arterial aneurysms in Behcet 's syndrome: a report of 24 eases显示文摘 | HAMURYUDAN V YURDAKUL S MORAL F | 1994 | Br J Rheumatol1994，33，1： | 1 |
| 4 | Enhancement of Solubility Via Esterification:Synthesis and Characterizationof Octakis(ester)-Substituted Phthalocyanines显示文摘 | BARBAROS AKKURT ESIN HAMURYUDAN | 2008 | Dyes and Pigments2008，79，： | 1 |
| 5 | Thalidonaide in the treatment of the mucocutaneous lesions of the Behqet syndrome A randomized, double-blind, placebo-controlled trial显示文摘 | Hamuryudan V Mat C Saip S | 1998 | Ann Intern Med1998，128，6： | 1 |
| 6 | Thalidomide in thetreatment of the mucacutaneous lesions of the Behcet syn- drome : a randomized, doubleblind, placebo, controlled trial 显示文摘 | Hamuryudan V Mat C Salp S | 1998 | Ann InternMed1998，128，6： | 1 |
| 7 | Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Beh?et’s disease显示文摘 | H. Direskeneli G. Keser D. D’Cruz M. A. Khamashta M.D. Ph.D. T. Ako?lu H. Yazici S. Yurdakul V. Hamuryudan ?. ?zgun A. J. Goral G. R. V. Hughes | 1995 | Clinical Rheumatology1995，，1： | 1 |
| 8 | Prognosis of Behcet'ssyndrome among men with mucocutaneous involvement atdisease onset: long-term outcome of patients enrolled in acontrolled trial显示文摘 | Hamuryudan V Hatemi G Tascilar K | 2010 | Rheumatology2010，49，1： | 1 |
| 9 | Behcet disease 显示文摘 | Yazici H Hurdakul S Hamuryudan V | 2001 | Curr Opin Rheclmatol2001，13，1： | 1 |
| 10 | Behcet's syndrome显示文摘 | Yazici H Yurdakul S Hamuryudan V | 1999 | Curr Opin Rheumatol1999，1，1： | 1 |
| 11 | Papulopustular skin lesions are seen more frequently in patients with Behcet's syndrome who have arthritis:a controlled and masked study显示文摘 | Diri E Mat C Hamuryudan V | | 0，，11： | 1 |
| 12 | Thalidomide has both anti-inflammatory and regulatory effects in Behcet’s disease显示文摘 | H. Direskeneli T. Ergun S. Yavuz V. Hamuryudan E. Eksioglu-Demiralp | 2008 | Clinical Rheumatology2008，，3： | 1 |
| 13 | Thalidomide in the treatment of the mucocutaneous lesions of the Behcet's desease syndrome:a randomized,double-blind,placebo-controlled trial显示文摘 | Hamuryudan V Mat C Saip S | 1998 | Ann Intern Med1998，128，： | 1 |
| 14 | Enteroclysis findings of intestinal Behcet disease: a comparative study with Crohn disease显示文摘 | U. Korman M. Cantasdemir S. Kurugoglu I. Mihmanli N. Soylu V. Hamuryudan H. Yazici | 2003 | Abdominal Imaging2003，，3： | 1 |
| 15 | Synthesis of Novel Unsymmetrical Phthalocyanines Substituted with Crown Ether and Nitro Groups显示文摘 | Arslanoglu Y Koca A Hamuryudan E | 2007 | Polyhedron2007，26，4： | 1 |
| 16 | Enhancement of Solubility via Es- terification: Synthesis and Characterization of Octakis (Ester)- Substituted Phthalocyanines 显示文摘 | Akkurt B Hamuryudan E | 2008 | Dyes Pigments''2008，79，2： | 1 |
| 17 | The frequency and clinical characteristics of methotrexate (MTX) oral toxicity in rheumatoid arthritis (RA): A masked and controlled study显示文摘 | Akgun Ince Y. Yazici V. Hamuryudan H. Yazici | 1996 | Clinical Rheumatology1996，，5： | 1 |
| 18 | The management of Behcet' s syndrome显示文摘 | Fresko l Yurdakul S Hamuryudan V | 1999 | Ann Med Interne1999，150，： | 1 |
| 19 | Azathioprine in Behcet Syndrome : effects on long - term prognosis 显示文摘 | Hamuryudan V Ozyazgan Y HJzli N | 1997 | Arthritis Rheum1997，40，4： | 1 |
| 20 | Azathioprine in Behcet's syndrome effects on long-term progronsis显示文摘 | Hamuryudan V Ozyazgan Y Hizli N | 1997 | Arthritis Rheum1997，40，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员